Edge Cure Pharmaceuticals (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 253.47%
- Profit Growth 104.06%
- Ebitda 70.74%
- Net Worth 2.95%
- Total Assets 12.04%
About Edge Cure Pharmaceuticals (Opc)
Edge Cure Pharmaceuticals (Opc) Private Limited (ECPOPL) is a Company incorporated in India on 16 July 2020 (Four years and six months 20 days old ). Its registered office is in Sultanpur, Uttar Pradesh, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Kumar serves as a director at the Company.
Company Details
-
Location
Sultanpur, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52520UP2020OPC131049
-
Company No.
131049
-
Incorporation Date
16 Jul 2020
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Edge Cure Pharmaceuticals (Opc)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Kumar
|
Managing Director | 16-Jul-2020 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Edge Cure Pharmaceuticals (Opc).
Edge Cure Pharmaceuticals (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 253.47% increase. The company also saw a substantial improvement in profitability, with a 104.06% increase in profit. The company's net worth moved up by a moderate rise of 2.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edge Cure Pharmaceuticals (Opc)?
Unlock access to Edge Cure Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edge Cure Pharmaceuticals (Opc)?
Edge Cure Pharmaceuticals (Opc) has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edge Cure Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edge Cure Pharmaceuticals (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.